Towards a Bio-Economy Superpower
India is entering a decisive phase of transformation where biology-led growth, deep-technology convergence, and civilisational values are shaping a new development model. The country’s bio-economy is not only expanding but evolving into a central pillar of national growth. Anchored in the vision of Viksit Bharat 2047, the projection of a $1 trillion bio-economy is supported by strong policy frameworks, institutional reforms, and a rapidly growing innovation ecosystem. This article examines India’s rise as a bio-economy leader through data trends, policy initiatives, scientific advancements, and global comparisons.
1. The Shift Towards a Biological Century
The 21st century is increasingly being recognised as the century of biology, where innovations in genomics, synthetic biology, and bio-manufacturing are redefining economic and industrial systems. Countries that successfully integrate biotechnology with digital and physical infrastructure are likely to dominate future global value chains. India’s emergence in this space reflects a strategic transition from a service-driven economy to a knowledge and innovation-led bio-economy.
At the Vision 2047 conference hosted at IIT Roorkee, Union Minister Dr. Jitendra Singh emphasised that India’s growth trajectory will be driven by a biology-based economy integrated with quantum, space, and ocean technologies. This perspective aligns with global research projections that highlight the increasing contribution of bio-economies to global GDP and industrial inputs.
2. Evolution of India’s Bio-Economy: A Decade of Accelerated Growth
India’s bio-economy has grown exponentially over the past decade, expanding from approximately $10 billion in 2014 to over $165 billion today. With a consistent annual growth rate of nearly 18 percent, it is projected to reach $300 billion by 2030 and scale up to $1 trillion by 2047.
A major driver of this growth has been the rapid expansion of the startup ecosystem. The number of biotech startups has surged from around 50 in 2014 to more than 11,000 today. This reflects improved access to funding, stronger incubation ecosystems, and supportive government policies. India is now recognised as one of the fastest-growing biotechnology ecosystems globally, particularly among emerging economies.
3. Policy Architecture: Enabling a Bio-Economic Revolution
The rise of India’s bio-economy is deeply rooted in a robust and forward-looking policy framework. The BioE3 Policy introduced in 2024 focuses on biotechnology for economy, environment, and employment, with a strong emphasis on bio-manufacturing and sustainable industrial growth. It integrates economic expansion with environmental responsibility, aligning India with global sustainability goals.
Institutional financing has also played a critical role. The establishment of the Anusandhan National Research Foundation with a corpus of ₹50,000 crore and the ₹1 lakh crore Research, Development and Innovation Fund has strengthened long-term investments in deep-tech innovation. These initiatives are complemented by increasing public-private partnerships and enhanced research infrastructure.
India’s improved ranking in the Global Innovation Index, rising from 81 to 39, reflects these structural advancements. It indicates significant progress in research output, intellectual property creation, and innovation-driven entrepreneurship.
4. Scientific Breakthroughs: From Research to Real-World Impact
India’s bio-economy growth is increasingly being driven by translational research that connects laboratory discoveries to real-world applications. The Genome India Project represents a major step in building a comprehensive genetic database, enabling advancements in precision medicine and personalised healthcare.
In the field of advanced therapies, India has made significant progress with the development of indigenous CAR-T cell therapy for cancer treatment. This innovation has the potential to drastically reduce treatment costs and improve accessibility. Additionally, the development of mRNA vaccine platforms has strengthened India’s capability to respond rapidly to future pandemics.
The country has also achieved milestones in bio-industrial innovation, including the development of its first indigenously produced antibiotic and the establishment of a National Biobank. These initiatives enhance both healthcare outcomes and industrial competitiveness.
5. Technological Convergence: From Gene to Qubit
A defining feature of India’s growth strategy is the convergence of multiple advanced technologies. Biotechnology is increasingly being integrated with quantum computing, enabling breakthroughs in drug discovery and complex biological simulations. The National Quantum Mission is playing a key role in advancing these capabilities.
Space biotechnology is another emerging frontier, with collaborations involving ISRO facilitating experiments in microgravity environments. Similarly, marine biotechnology initiatives such as Samudrayaan are exploring deep-sea biodiversity for pharmaceutical and industrial applications.
This full-spectrum approach, spanning biology, quantum science, space, and ocean technologies, positions India uniquely in the global innovation ecosystem.
6. Civilisational Ethos and Development Model
India’s development pathway is distinguished by its integration of economic progress with ethical values. The guiding principle of “Arthasya Moolam Dharmam” reflects a model where economic activities are rooted in moral and societal responsibility. This approach ensures that growth remains sustainable, inclusive, and aligned with long-term societal well-being.
Such a framework offers an alternative to purely profit-driven development models and is increasingly relevant in addressing global challenges such as climate change, inequality, and resource depletion.
7. Global Comparison: India’s Emerging Advantage
In comparison with leading bio-economies such as the United States and China, India stands out for its rapid growth rate and cost-effective innovation model. While advanced economies have higher R&D investments, India’s strength lies in its large talent pool, strong integration of IT and biotechnology, and an increasingly vibrant startup ecosystem.
India’s hybrid model, combining state support with entrepreneurial dynamism, is enabling it to scale rapidly while maintaining flexibility and inclusivity.
8. Roadmap to 2047: Strategic Milestones
India has laid out a clear roadmap for its bio-economy growth. By 2030, the sector is expected to reach $300 billion, followed by leadership in bio-manufacturing by 2035. By 2040, deeper integration with carbon-neutral and sustainable technologies is anticipated. The ultimate goal is to position India among the top three global bio-economies by 2047 with a valuation of $1 trillion.
Key milestones also include the operationalisation of the Bharatiya Antariksha Station, expansion of marine and space biotechnology, and scaling up of deep-tech startups.
9.Challenges and Strategic Imperatives
Despite strong progress, India faces several structural challenges. Research and development expenditure, although increasing, remains lower than global benchmarks. Regulatory complexities in biotechnology approvals can slow down innovation cycles. Additionally, talent retention and infrastructure development in emerging innovation hubs require sustained attention.
Addressing these challenges will be essential to maintain momentum and achieve long-term strategic goals.
India’s journey towards a $1 trillion bio-economy represents more than economic growth; it signifies a transformation into a knowledge-driven, innovation-led civilisation. The convergence of policy vision, scientific advancements, and cultural ethos positions India as a future global leader.
The role of the young “Amrit Generation” will be critical in this transformation. As India strengthens its position in global innovation and technology leadership, the assertion that the 21st century belongs to Bharat is increasingly supported by both data and direction.
